Dexamethasone and interleukin-1 potently synergize to stimulate the production of granulocyte colony-stimulating factor in differentiated THP-1 cells

Biochem Biophys Res Commun. 1997 Oct 29;239(3):676-80. doi: 10.1006/bbrc.1997.7533.

Abstract

The human monocytic leukemic cell line, THP-1, which differentiates toward macrophages in response to phorbol 12-myristate 13-acetate (PMA) was investigated for its ability to produce granulocyte colony-stimulating factor (G-CSF). G-CSF protein was neither produced during PMA-induced differentiation nor in response to dexamethasone (Dex) alone. However, when combined, PMA and Dex synergistically stimulated THP-1 cells to produce G-CSF. The synergistic interaction between PMA and Dex on G-CSF production appeared to be mediated through the production of interleukin-1 (IL-1) since neutralization of IL-1 activity completely inhibited G-CSF production. Further experiments demonstrated that in THP-1 cells pretreated with PMA, Dex potently synergized with IL-1 to stimulate G-CSF production.

MeSH terms

  • Cell Differentiation
  • Dexamethasone / pharmacology*
  • Drug Synergism
  • Granulocyte Colony-Stimulating Factor / biosynthesis*
  • Granulocyte Colony-Stimulating Factor / drug effects
  • Humans
  • Infant
  • Interleukin-1 / biosynthesis
  • Interleukin-1 / pharmacology*
  • Interleukin-1 / physiology
  • Leukemia, Monocytic, Acute / metabolism*
  • Leukemia, Monocytic, Acute / pathology
  • Male
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Granulocyte Colony-Stimulating Factor
  • Dexamethasone
  • Tetradecanoylphorbol Acetate